DL-(2-AMINO-2-CARBOXYETHYL)-HOMOCYSTEINE-3,3,4,4-D4(146764-57-0)
- Name: DL-(2-AMINO-2-CARBOXYETHYL)-HOMOCYSTEINE-3,3,4,4-D4
- Synonyms:DL-Homocysteine-3,3,4,4-d4,S-(2-amino-2-carboxyethyl)-
- Molecular Formula:C7H10 D4 N2 O4 S
- Molecular Weight:226.29
- CAS Registry Number:146764-57-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.146764-57-0 D,L-Cystathionine-d4 (Major)
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.146764-57-0 Homocysteine-3,3,4,4-d4,S-(2-amino-2-carboxyethyl)- (9CI)
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)] CAS No.146764-57-0 DL-Cystathionine-[3,3,4,4-d4]
Assay:98% by HPLC; 98% atom D Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 146741-06-2/2(1H)-Quinoxalinone,6-fluoro-3,4-dihydro-3-methyl-(9CI)
- 146743-95-5/3-Isoquinolinecarboxylic acid, 6,7-dihydroxy- (9CI)
- 146743-96-6/3-Isoquinolinecarboxylic acid, 7,8-dihydroxy- (9CI)
- 142479-62-7/DELTA-OPIOID RECEPTOR PEPTIDE TRIFLUOROACETATE SALT
- 142483-61-2/1-Azabicyclo[3.2.1]octane, 5-ethynyl- (9CI)
- 142493-78-5/7H-Pyrrolo[2,3-d]pyridazin-7-one,1,6-dihydro-2,3-dimethyl-(9CI)
- 142494-33-5/1,2-Cyclobutanedimethanol,3-amino-alpha2-methyl-(9CI)
- 142502-76-9/2-(PERFLUORO-N-HEXYL)ACETALDEHYDE DIMETHYL ACETAL
- 142502-88-3/2(1H)-Pyridinone,3-ethynyl-(9CI)
- 142503-05-7/3-Pyridinol,2-ethynyl-(9CI)
- 142503-06-8/3-Pyridinol,4-ethynyl-(9CI)
- 142503-07-9/4-Pyridinol,3-ethynyl-(9CI)
- 146764-24-1/4-HYDROXY NONENAL MERCAPTURIC ACID
- 142505-10-0/Pyridine, 3-(1-butenyl)-, (Z)- (9CI)
- 142505-11-1/Pyridine, 3-(1-butenyl)-, (E)- (9CI)
- 146764-32-1/2-(4-DIMETHYLAMINOSTYRYL)-1-OCTADECYLPYRIDINIUM PERCHLORATE
- 142505-62-2/[1,1-Biphenyl]-2-amine,2-ethoxy-(9CI)
- 146764-52-5/alpha-D-erythro-Pentofuranoside,ethyl2-deoxy-3-O-(1-methylethyl)-(9CI)
- 146764-53-6/ba-D-erythro-Pentofuranoside, ethyl 2-deoxy-3-O-(1-methylethyl)- (9CI)
- 146764-57-0/DL-(2-AMINO-2-CARBOXYETHYL)-HOMOCYSTEINE-3,3,4,4-D4
- 146774-88-1/4(3H)-Quinolinone, 2-(4-bromophenyl)-3,3-dichloro-
- 146780-26-9/5-CHLORO-2,4-DIFLUOROBENZONITRILE
- 146780-79-2/2,4(1H,3H)-Pyrimidinedione,5-fluoro-6-methoxy-(9CI)
- 146781-28-4/4-ETHOXYMETHYL-BENZOIC ACID
- 146781-64-8/Cray Valley EHR 100/3
- 146781-74-0/1H-2,6a-Diazacyclobut[cd]indene(9CI)
- 146781-77-3/2H-Pyrrolo[2,3-f]-1,2-benzisoxazole(9CI)
- 146781-78-4/2H-Pyrrolo[3,2-f]-1,2-benzisoxazole(9CI)
- 142540-43-0/2-Oxepanone, homopolymer, ester with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 2-propenoate
- 142542-47-0/(R)-2-[3-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoic acid methyl ester